Repubblika Ċeka - Ċek - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 651 furosemid - tableta - 250mg - furosemid

Repubblika Ċeka - Ċek - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 651 furosemid - tableta - 40mg - furosemid

Repubblika Ċeka - Ċek - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 651 furosemid - tableta - 500mg - furosemid

Unjoni Ewropea - Ċek - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 a 5.

Unjoni Ewropea - Ċek - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomid - roztroušená skleróza - selektivní imunosupresiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Unjoni Ewropea - Ċek - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Unjoni Ewropea - Ċek - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva, selektivní imunosupresiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Repubblika Ċeka - Ċek - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 15618 teriflunomid - potahovaná tableta - 14mg - teriflunomid

Repubblika Ċeka - Ċek - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 4442 atenolol - potahovaná tableta - 100mg - atenolol

Repubblika Ċeka - Ċek - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 4442 atenolol - potahovaná tableta - 25mg - atenolol